Omeprazole vs. ranitidine in the short-term treatment of duodenal ulcer

An Italian multicenter study

L. Barbara, A. Blasi, R. Cheli, R. Corinaldesi, G. Dobrilla, A. Francavilla, M. Rinetti, P. Vezzaldini, R. Abbiati, R. Gradnik, G. Ciancamerla, F. Chilovi, M. Felder, M. Ingrosso, A. Mangiameli, A. Paternico, R. Sivelli, P. Tomassetti, G. Labo

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

A double-blind, double-dummy, randomized Italian multicenter trial was carried out to compare the efficacy and safety of omeprazole 20 mg in the morning and ranitidine 150 mg b.i.d. in short-term treatment of acute duodenal ulcer. One hundred and twenty-one patients (61 in the omeprazole and 60 in the ranitidine group) with endoscopically proven active duodenal ulcer, completed the study. The healing rates after 2, 4 and 6 weeks were 66, 97 and 100%, respectively, with omeprazole and 53, 85 and 92%, respectively, with ranitidine. The difference was statistically significant (p

Original languageEnglish
Pages (from-to)229-232
Number of pages4
JournalHepato-Gastroenterology
Volume34
Issue number5
Publication statusPublished - 1987

Fingerprint

Ranitidine
Omeprazole
Duodenal Ulcer
Multicenter Studies
Therapeutics
Safety

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Barbara, L., Blasi, A., Cheli, R., Corinaldesi, R., Dobrilla, G., Francavilla, A., ... Labo, G. (1987). Omeprazole vs. ranitidine in the short-term treatment of duodenal ulcer: An Italian multicenter study. Hepato-Gastroenterology, 34(5), 229-232.

Omeprazole vs. ranitidine in the short-term treatment of duodenal ulcer : An Italian multicenter study. / Barbara, L.; Blasi, A.; Cheli, R.; Corinaldesi, R.; Dobrilla, G.; Francavilla, A.; Rinetti, M.; Vezzaldini, P.; Abbiati, R.; Gradnik, R.; Ciancamerla, G.; Chilovi, F.; Felder, M.; Ingrosso, M.; Mangiameli, A.; Paternico, A.; Sivelli, R.; Tomassetti, P.; Labo, G.

In: Hepato-Gastroenterology, Vol. 34, No. 5, 1987, p. 229-232.

Research output: Contribution to journalArticle

Barbara, L, Blasi, A, Cheli, R, Corinaldesi, R, Dobrilla, G, Francavilla, A, Rinetti, M, Vezzaldini, P, Abbiati, R, Gradnik, R, Ciancamerla, G, Chilovi, F, Felder, M, Ingrosso, M, Mangiameli, A, Paternico, A, Sivelli, R, Tomassetti, P & Labo, G 1987, 'Omeprazole vs. ranitidine in the short-term treatment of duodenal ulcer: An Italian multicenter study', Hepato-Gastroenterology, vol. 34, no. 5, pp. 229-232.
Barbara L, Blasi A, Cheli R, Corinaldesi R, Dobrilla G, Francavilla A et al. Omeprazole vs. ranitidine in the short-term treatment of duodenal ulcer: An Italian multicenter study. Hepato-Gastroenterology. 1987;34(5):229-232.
Barbara, L. ; Blasi, A. ; Cheli, R. ; Corinaldesi, R. ; Dobrilla, G. ; Francavilla, A. ; Rinetti, M. ; Vezzaldini, P. ; Abbiati, R. ; Gradnik, R. ; Ciancamerla, G. ; Chilovi, F. ; Felder, M. ; Ingrosso, M. ; Mangiameli, A. ; Paternico, A. ; Sivelli, R. ; Tomassetti, P. ; Labo, G. / Omeprazole vs. ranitidine in the short-term treatment of duodenal ulcer : An Italian multicenter study. In: Hepato-Gastroenterology. 1987 ; Vol. 34, No. 5. pp. 229-232.
@article{35dcd5d39ec3441cb13966877de652e8,
title = "Omeprazole vs. ranitidine in the short-term treatment of duodenal ulcer: An Italian multicenter study",
abstract = "A double-blind, double-dummy, randomized Italian multicenter trial was carried out to compare the efficacy and safety of omeprazole 20 mg in the morning and ranitidine 150 mg b.i.d. in short-term treatment of acute duodenal ulcer. One hundred and twenty-one patients (61 in the omeprazole and 60 in the ranitidine group) with endoscopically proven active duodenal ulcer, completed the study. The healing rates after 2, 4 and 6 weeks were 66, 97 and 100{\%}, respectively, with omeprazole and 53, 85 and 92{\%}, respectively, with ranitidine. The difference was statistically significant (p",
author = "L. Barbara and A. Blasi and R. Cheli and R. Corinaldesi and G. Dobrilla and A. Francavilla and M. Rinetti and P. Vezzaldini and R. Abbiati and R. Gradnik and G. Ciancamerla and F. Chilovi and M. Felder and M. Ingrosso and A. Mangiameli and A. Paternico and R. Sivelli and P. Tomassetti and G. Labo",
year = "1987",
language = "English",
volume = "34",
pages = "229--232",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "5",

}

TY - JOUR

T1 - Omeprazole vs. ranitidine in the short-term treatment of duodenal ulcer

T2 - An Italian multicenter study

AU - Barbara, L.

AU - Blasi, A.

AU - Cheli, R.

AU - Corinaldesi, R.

AU - Dobrilla, G.

AU - Francavilla, A.

AU - Rinetti, M.

AU - Vezzaldini, P.

AU - Abbiati, R.

AU - Gradnik, R.

AU - Ciancamerla, G.

AU - Chilovi, F.

AU - Felder, M.

AU - Ingrosso, M.

AU - Mangiameli, A.

AU - Paternico, A.

AU - Sivelli, R.

AU - Tomassetti, P.

AU - Labo, G.

PY - 1987

Y1 - 1987

N2 - A double-blind, double-dummy, randomized Italian multicenter trial was carried out to compare the efficacy and safety of omeprazole 20 mg in the morning and ranitidine 150 mg b.i.d. in short-term treatment of acute duodenal ulcer. One hundred and twenty-one patients (61 in the omeprazole and 60 in the ranitidine group) with endoscopically proven active duodenal ulcer, completed the study. The healing rates after 2, 4 and 6 weeks were 66, 97 and 100%, respectively, with omeprazole and 53, 85 and 92%, respectively, with ranitidine. The difference was statistically significant (p

AB - A double-blind, double-dummy, randomized Italian multicenter trial was carried out to compare the efficacy and safety of omeprazole 20 mg in the morning and ranitidine 150 mg b.i.d. in short-term treatment of acute duodenal ulcer. One hundred and twenty-one patients (61 in the omeprazole and 60 in the ranitidine group) with endoscopically proven active duodenal ulcer, completed the study. The healing rates after 2, 4 and 6 weeks were 66, 97 and 100%, respectively, with omeprazole and 53, 85 and 92%, respectively, with ranitidine. The difference was statistically significant (p

UR - http://www.scopus.com/inward/record.url?scp=0023265269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023265269&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - 229

EP - 232

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 5

ER -